Supply Constraint of Sarilumab [Kevzara®]

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Kevzara
Active substance
sarilumab
Therapeutic area (MeSH)
Arthritis, Rheumatoid
Regulatory outcome
Variation
DHPC type
Medicine shortage
Human ATC code
L04AC14
Dissemination date
09/11/2021

How useful was this page?

Add your rating